Phathom Pharmaceuticals, Inc.·4

May 30, 6:46 PM ET

COLA MICHAEL F 4

4 · Phathom Pharmaceuticals, Inc. · Filed May 30, 2023

Insider Transaction Report

Form 4
Period: 2023-05-25
Transactions
  • Award

    Common Stock

    2023-05-25+9,00018,798 total
  • Award

    Stock Option (Right to Buy)

    2023-05-25+15,00015,000 total
    Exercise: $11.72Exp: 2033-05-24Common Stock (15,000 underlying)
Footnotes (2)
  • [F1]The Restricted Stock Units ("RSUs") were granted on May 25, 2023, pursuant to the Issuer's Non-Employee Director Compensation Program. 100% of the total number of RSUs granted shall vest on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing service on the Board through such vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
  • [F2]The option was granted pursuant to the Issuer's Non-Employee Director Compensation Program. The option shall vest and/or become exercisable on the first to occur of (A) the first anniversary of the date of grant or (B) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continuing in service on the Board through such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION